Michael Lingzhi Li is an Assistant Professor in the Technology and Operations Management unit at Harvard Business School. He is passionate about combining causal inference, optimization, and machine learning to develop AI-driven decision algorithms to accelerate clinical trials worldwide. His recent joint work with Janssen Pharmaceuticals in accelerating the COVID-19 vaccine Phase III trial was awarded the Innovative Applications in Analytics Award.